BMYMP News and Press, Bristol-Myers Squibb $2Pr From 10/26/23

2023-10-26 00:58:27 ET Summary In this series, I rank a selection of Dividend Radar stocks and present the ten top-ranked stocks for further research and possible investment. I screened for high-quality stocks with superior growth and income prospects this month. Additionally, I s...

2023-10-16 01:21:15 ET Summary In 2015, I started publishing updates regarding my dividend growth portfolio, and I keep doing so every quarter. This is part of being transparent with my readers, so they can see what I hold and its correlation with my writing. This article summ...

2023-10-10 17:16:20 ET Summary Distillate U.S. Fundamental Stability & Value ETF picks stocks based on criteria including cash flow yield, cash flow stability, and debt. The DSTL ETF's top sectors are healthcare, technology and industrials. It is not only a value ETF, but ...

2023-10-06 18:09:48 ET Summary The biotechnology and pharmaceutical sectors have been under pressure in 2023, with the Invesco Pharmaceuticals ETF down 9% and the iShares Biotechnology ETF down 6%. Elevated interest rates and potential pricing power erosion are the primary headwin...

2023-10-04 03:04:43 ET Summary Our 3-step process focuses on wide-moat stocks (as per Morningstar’s rating). We are only interested in those targets that are attractively valued in historical comparison. We share the heat map of the most investable candidates that may b...

2023-09-26 12:20:20 ET Summary I examine the applicability of relative R&D spending as a potential leading indicator of shareholder returns. In addition, the correlation of R&D spending with stock volatility and sales growth is examined. It's found that high R&D sp...

2023-09-20 08:59:31 ET More on Bristol-Myers Squibb Company PFD CONV 2 Historical earnings data for Bristol-Myers Squibb Company PFD CONV 2 Dividend scorecard for Bristol-Myers Squibb Company PFD CONV 2 Financial information for Bristol-Myers Squibb Company PFD CONV ...

2023-09-19 14:45:33 ET Summary Regeneron Pharmaceuticals, Inc. is a pharmaceutical company headquartered in Tarrytown that has played a key role in the fight against COVID-19. Regeneron's revenue for the second quarter of 2023 was $3.16 billion, an increase of 10.5% compared to th...

2023-09-11 10:15:27 ET Bristol-Myers Squibb Company (BMY) Morgan Stanley 21st Annual Global Healthcare Conference September 11, 2023 08:00 AM ET Company Participants Giovanni Caforio - Chairman of the Board & CEO Christopher Boerner - EVP & COO Conferen...

2023-08-24 02:20:26 ET Summary Bristol-Myers has a strong history of investment outperformance during equity bear markets and recessions. The company is uniquely undervalued, with a low 8x P/E and nearly 4% cash dividend yield. After a weak first half of 2023, shares may rebou...